Page last updated: 2024-09-04

ezetimibe and D-fructopyranose

ezetimibe has been researched along with D-fructopyranose in 1 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (D-fructopyranose)	Trials (D-fructopyranose)	Recent Studies (post-2010) (D-fructopyranose)
2,484	563	1,465	18,095	1,041	5,633

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kashiwagi, A; Kume, S; Maegawa, H; Maeno, Y; Morino, K; Nagai, Y; Nishio, Y; Sekine, O; Ugi, S; Ushio, M; Yoshizaki, T	1

Other Studies

1 other study(ies) available for ezetimibe and D-fructopyranose

Article	Year
Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet. American journal of physiology. Endocrinology and metabolism, 2013, Jul-15, Volume: 305, Issue:2 Topics: Animals; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Azo Compounds; Blotting, Western; Cell Nucleus; Diet; Diet, High-Fat; Electrophoretic Mobility Shift Assay; Enterocytes; Ezetimibe; Fatty Liver; Fructose; Glucose Tolerance Test; Intestinal Mucosa; Intestines; Lipid Metabolism; Lipoproteins; Liver; Male; Mice; Mice, Inbred CBA; Pyruvic Acid; Real-Time Polymerase Chain Reaction; RNA	2013

Article

Year

Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.

American journal of physiology. Endocrinology and metabolism, 2013, Jul-15, Volume: 305, Issue:2

Topics: Animals; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Azo Compounds; Blotting, Western; Cell Nucleus; Diet; Diet, High-Fat; Electrophoretic Mobility Shift Assay; Enterocytes; Ezetimibe; Fatty Liver; Fructose; Glucose Tolerance Test; Intestinal Mucosa; Intestines; Lipid Metabolism; Lipoproteins; Liver; Male; Mice; Mice, Inbred CBA; Pyruvic Acid; Real-Time Polymerase Chain Reaction; RNA

2013